Tempus
AI precision medicine company
Company Facts
About Tempus
Tempus is a precision medicine company that uses AI to analyze clinical and molecular data to deliver personalized treatment insights.
What is Tempus?
Tempus is a technology company focused on precision medicine, leveraging AI and data to improve patient outcomes, particularly in cancer care. It has developed a comprehensive library of clinical and molecular data to support healthcare providers and researchers.
Who is Tempus for?
Tempus serves healthcare providers, pharmaceutical companies, and patients. It aims to empower physicians with data to personalize treatment plans and assist drug developers in creating targeted therapies.
When was Tempus founded?
Tempus was founded in 2015 by Eric Lefkofsky. The company was established to harness the power of data and artificial intelligence in the field of precision medicine.
Who founded Tempus?
Tempus was founded by Eric Lefkofsky, an entrepreneur with a vision to transform healthcare through data-driven insights and technology.
What is Tempus best known for?
Tempus is best known for its extensive library of clinical and molecular data and its innovative AI-driven solutions that enhance precision medicine, particularly in cancer treatment.
Where AI Leaders Stay Informed
The latest AI intelligence, case studies, and research — delivered to your inbox every week.
Free to read. Unsubscribe anytime.
Is this your company?
Claim this profile to manage information and unlock premium features.